TDO2 and central nervous system cancer: NTRC 3531‐0 also inhibited mouse TDO (mTDO) in a biochemical assay and in a cellular assay based on a mouse glioma GL‐261 cell line stably overexpressing the full‐length mouse TDO2 cDNA (GL‐261‐mTDO) (Table 1).